Presently, the situation of chronic hepatitis B combined with non-alcoholic fatty liver disease is relatively common in our country, and yet the relationship between them has not reached a consensus. The co-existing fatty liver may affect the efficacy of anti-HBV therapy and increase the all-cause mortality rates in patients. Therefore, it is very important to correctly diagnose and evaluate fatty liver changes, inflammation, and fibrosis for active prevention and treatment.
目前我国慢性乙型肝炎合并非酒精性脂肪性肝病情况比较常见，乙型肝炎病毒感染与脂肪肝之间关系仍未达成共识，合并的脂肪肝可能会影响患者的抗乙型肝炎病毒治疗效果、增加患者的全因死亡率。所以正确诊断、评估患者肝脏脂肪变、炎症、纤维化等情况，并积极防治脂肪肝非常重要。.
Keywords: Diagnosis; Fatty liver; Hepatitis B virus; Therapy.